Free Trial
BATS:ARKG

ARK Genomic Revolution ETF (ARKG) Price, Holdings, & News

ARK Genomic Revolution ETF logo
$24.01 +0.40 (+1.71%)
As of 11:49 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About ARK Genomic Revolution ETF (BATS:ARKG)

Key Stats

Today's Range
$24.20
$25.24
50-Day Range
$22.12
$26.56
52-Week Range
$17.51
$31.16
Volume
4.90 million shs
Average Volume
2.73 million shs
Market Capitalization
$1.07 billion
Assets Under Management
$989.97 million
Dividend Yield
N/A
Net Expense Ratio
0.75%
Aggregate Rating
Moderate Buy

ETF Overview

ARK Genomic Revolution ETF Expenses

TypeARKGTheme ETFsEquity ETFsBATS ETFsAll ETFs
Management Fee0.75%0.57%0.56%0.57%0.53%
Other Expenses0.00%0.57%0.56%0.48%0.56%
Total Expense0.75%0.74%0.76%0.71%0.73%
Fee Waiver0.00%-0.76%-0.66%-0.46%-0.63%
Net Expense0.75%0.60%0.63%0.64%0.60%
Receive ARKG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARK Genomic Revolution ETF and its competitors with MarketBeat's FREE daily newsletter.

ARKG ETF News Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
ARK Genomic Revolution ETF (ARKG) - Yahoo Finance
ARK Genomic Revolution ETF (ARKG) Risk - Yahoo Finance
See More Headlines

ARKG ETF - Frequently Asked Questions

ARK Genomic Revolution ETF's stock was trading at $23.5450 on January 1st, 2025. Since then, ARKG shares have decreased by 0.7% and is now trading at $23.3810.

ARK Genomic Revolution ETF's top institutional investors include Kingstone Capital Partners Texas LLC (0.35%), Prudential PLC (0.31%), Cetera Investment Advisers (0.21%) and Bank of Montreal Can (0.15%).

Shares of ARKG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ARK Genomic Revolution ETF investors own include Invesco QQQ (QQQ), ARK Innovation ETF (ARKK), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), AbbVie (ABBV) and PayPal (PYPL).

Fund Details

Issuer
ARK
Fund Name
ARK Genomic Revolution ETF
Tax Classification
Regulated Investment Company
Stock Exchange
BATS
Current Symbol
BATS:ARKG
Inception Date
10/31/2014
Fund Manager
Catherine Wood
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
38

Fund Statistics

Assets Under Management
$989.80 million
Average Daily Volume
$2.43 million
Discount/Premium
0.01%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
ARK Investment Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
Optionable
Options Volume
2,491
Put Options
559
Call Options
1,932

Miscellaneous

Beta
1.62
Creation Unit
50,000
Creation Fee
$500.00
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Top 10 ARKG Holdings

ARKG Sector Exposure

ARKG Industry Exposure


This page (BATS:ARKG) was last updated on 8/12/2025 by MarketBeat.com Staff
From Our Partners